BeneTalk Revenue and Competitors

Groundbreaking technology to learn and track new speaking habits. 1 out of 10 people suffer from speech and language difficulties. This profoundly affects their professional and social life and there is no viable technological solution to solve this problem. In the US alone, 40 million people suffer from Speech, Language and Communication Disorders, costing the U.S. approximately $154–186 billion annually. BeneTalk is a digital coach and tracker for fluency therapy. Unlike other alternatives, we provide affordable personalised therapy on demand and objective fluency progression during the day (‘Fitbit' for fluency). Digital therapy is delivered without Speech & Language Therapists' intervention, by measuring speech patterns, physiological activity and developing AI models around proven fluency methods. BeneTalk's vision is transforming the lives of everyone affected from speech disorders by improving their communication skills and allowing them to communicate effectively, irrespective of their geographical location, condition and financial situation. To achieve this, we assembled a rockstar team to build, grow and scale a company which has the potential to transform the lives of 700m people. Based in London, Respira is lucky to have the support from InnovateUK, UK Universities and charities such as the British Stammering Association, AnxietyUK and the Stammer Trust.